創薬サービスの世界市場予測(~2022年):医薬品化学、生物学サービス、DMPK

◆英語タイトル:Drug Discovery Services Market by Process (Target Selection, Hit-to-Lead Identification, Lead Optimization), Type (Medicinal Chemistry, Biology Services, DMPK), Drug Type (Small Molecules, Biologics), Therapeutic Areas (Oncology, Neurology) - Forecast to 2022
◆商品コード:PH-5682
◆発行会社(調査会社):MarketsandMarkets
◆発行日:2017年10月27日
◆ページ数:170
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:製薬
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥638,450見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥751,450見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥920,950見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規販売代理店です。MarketsandMarkets社の概要及び新刊レポートはこちらでご確認いただけます。
MarketsandMarketsが発行した当調査レポートでは、創薬サービスの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、プロセス別分析、種類別分析、薬品タイプ別分析、治療分野別分析、創薬サービスの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。
【レポートの概要】

Drug discovery services are widely used in forensics, paternity testing, disaster victim identification, and anthropology with DNA analysis/profiling being a key tool in this sector. The global drug discovery services market is expected to reach USD 14.40 Billion by 2022 from USD 8.32 Billion in 2017, at a CAGR of 11.6%. The major factors driving the growth of this market are increasing research and development expenditure, inclination of major pharmaceutical companies towards outsourcing to avoid hurdles, and increasing demand for outsourcing of analytical testing and clinical trial services.
The drug discovery services market is segmented on the basis of process, type, drug type, and therapeutic area. On the basis of process, the global market is segmented into target selection, target validation, hit-to-lead identification, lead optimization, and candidate validation. The hit-to-lead identification segment is expected to account for the largest share of the market in 2017. The growth in this segment is primarily attributed to emerging advanced technologies for high-throughput screening (HTS).

Based on type, the drug discovery services market is segmented into medicinal chemistry, biology services, and drug metabolism and pharmacokinetics (DMPK). In 2017, the medicinal chemistry segment is expected to account for the largest share of the market. Increasing R&D expenditure, growing number of drug discovery and developmental activities, and increasing inclination of pharmaceutical companies towards outsourcing are among the major factors driving the growth of the medicinal chemistry segment.

On the basis of drug type, the drug discovery services market is segmented into small molecules and biologics. In 2017, the small molecules segment is expected to account for the largest share of the global market. Small molecule drugs are simple, well defined, and easy to characterize. Due to their features, they can easily enter cells, affect other molecules, and cause cancer cells to die. As a result, many targeted therapies are small molecules or small-molecule inhibitors.

By therapeutic area, the drug discovery services market is segmented into oncology, neurology, cardiovascular diseases, respiratory diseases, diabetes, and other therapeutic areas. In 2017, the oncology segment is expected to account for the largest share of the global market. The market is mainly driven by increasing number of cancer patients, which leads to a high demand for cancer therapies.

By region, the drug discovery services market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). The market is dominated by North America, followed by Europe. However, the Asia Pacific region is expected to witness the highest growth during the forecast period due to less stringent regulations and economical manufacturing costs.

The high cost involved in drug discovery & development and stringent regulations governing drug discovery and animal usage are expected to restrain market growth during the forecast period.

Albany Molecular Research Inc. (AMRI) (US), Charles River Laboratories (US), Evotec (Germany), Domainex (UK), GenScript (US), Covance (US), WuXi AppTec (China), Pharmaceutical Product Development, LLC (PPD) (US), Jubilant Biosys (India), GE Healthcare (US), Merck (Germany), Piramal Enterprises (India), and Advinus Therapeutics (India) are some of the leading players in this market.

【レポートの目次】

1 Introduction (Page No. – 16)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 19)
2.1 Research Data
2.2 Secondary Data
2.2.1 Key Data From Secondary Sources
2.3 Primary Data
2.3.1 Key Data From Primary Sources
2.4 Market Size Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Data Triangulation
2.6 Assumptions for the Study

3 Executive Summary (Page No. – 27)

4 Premium Insights (Page No. – 32)
4.1 Drug Discovery Services Market Overview
4.2 European Market Share, By Therapeutic Area and Country
4.3 Global Market, By Type
4.4 Geographical Snapshot of the Global Market

5 Market Overview (Page No. – 36)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing R&D Expenditure
5.2.1.2 Increasing Demand for Outsourcing Analytical Testing and Clinical Trial Services
5.2.1.3 Initiatives for Research on Rare Diseases
5.2.1.4 Focus on Drug Discovery
5.2.2 Restraints
5.2.2.1 High Cost of Drug Discovery and Development
5.2.2.2 Stringent Regulations Governing Drug Discovery, and Animal Usage
5.2.3 Opportunities
5.2.3.1 Introduction of Advanced Technologies
5.2.3.2 Patent Expiries to Boost the Demand for Drug Discovery
5.2.4 Burning Issues
5.2.4.1 Need for Harmonization of Regulations, Ip Rights

6 Drug Discovery Services Market, By Process (Page No. – 44)
6.1 Introduction
6.2 Target Selection
6.3 Target Validation
6.4 Hit-To-Lead Identification
6.5 Lead Optimization
6.6 Candidate Validation

7 Drug Discovery Services Market, By Type (Page No. – 51)
7.1 Introduction
7.2 Medicinal Chemistry
7.3 Biology Services
7.4 Drug Metabolism and Pharmacokinetics (DMPK)

8 Drug Discovery Services Market, By Drug Type (Page No. – 56)
8.1 Introduction
8.2 Small Molecules
8.3 Biologics

9 Drug Discovery Services Market, By Therapeutic Area (Page No. – 60)
9.1 Introduction
9.2 Oncology
9.3 Neurology
9.4 Cardiovascular Diseases
9.5 Respiratory Diseases
9.6 Diabetes
9.7 Other Therapeutic Areas

10 Drug Discovery Services Market, By Region (Page No. – 69)
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Rest of Europe (RoE)
10.4 Asia Pacific (APAC)
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Rest of Asia Pacific (RoAPAC)
10.5 Rest of the World (RoW)

11 Competitive Landscape (Page No. – 115)
11.1 Market Share Analysis

12 Company Profiles (Page No. – 116)
(Overview, Strength of Product Portfolio, Business Strategy Excellence, Products Offering, and Recent Developments)*
12.1 Thermo Fisher Scientific
12.2 Merck
12.3 GE Healthcare
12.4 Albany Molecular Research, Inc. (AMRI)
12.5 Charles River Laboratories International
12.6 Evotec
12.7 Pharmaceutical Product Development, LLC. (Ppd)
12.8 Jubilant Biosys
12.9 Covance
12.10 Genscript Biotech Corporation
12.11 Aurigene Discovery Technologies
12.12 Wuxi Apptec
12.13 Syngene

*Details on Overview, Strength of Product Portfolio, Business Strategy Excellence, Products Offering, and Recent Developments Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. – 159)
13.1 Industry Insights
13.2 Discussion Guide
13.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.4 Introducing RT: Real-Time Market Intelligence
13.5 Available Customizations
13.6 Related Reports
13.7 Author Details

List of Tables (92 Tables)

Table 1 Total Global Pharmaceutical R&D Spending, 2012 to 2022 (USD Billion)
Table 2 R&D Spending, Phrma Member-Companies (USD Billion)
Table 3 Activities Outsourced in the Pharmaceutical Industry (2014 vs 2015)
Table 4 Research Projects Funded By Irdirc Bodies
Table 5 Average Cost of Drugs Approved By Year
Table 6 Drug Discovery Services Market, By Process, 2015–2022 (USD Million)
Table 7 Target Selection Market, By Region, 2015–2022 (USD Million)
Table 8 Target Validation Market, By Region, 2015–2022 (USD Million)
Table 9 Hit-To-Lead Identification Process Market, By Region, 2015–2022 (USD Million)
Table 10 Lead Optimization Market, By Region, 2015–2022 (USD Million)
Table 11 Candidate Validation Market, By Region, 2015–2022 (USD Million)
Table 12 Drug Discovery Services Market, By Type, 2015–2022 (USD Million)
Table 13 Medicinal Chemistry Services Market, By Region, 2015–2022 (USD Million)
Table 14 Biology Services Market, By Region, 2015–2022 (USD Million)
Table 15 Drug Metabolism and Pharmacokinetics Services Market, By Region, 2015–2022 (USD Million)
Table 16 Drug Discovery Services Market, By Drug Type, 2015–2022 (USD Million)
Table 17 Small Molecules Market, By Region, 2015–2022 (USD Million)
Table 18 Biologics Market, By Region, 2015–2022 (USD Million)
Table 19 Global Number of Clinical Trials in Different Therapeutic Areas, 2016
Table 20 Global Drug Discovery Services Market, By Therapeutic Area, 2015–2022 (USD Million)
Table 21 Market for Oncology, By Region, 2015–2022 (USD Million)
Table 22 Market for Neurology, By Region, 2015–2022 (USD Million)
Table 23 Market for Cardiovascular Diseases, By Region, 2015–2022 (USD Million)
Table 24 Market for Respiratory Diseases, By Region, 2015–2022 (USD Million)
Table 25 Drug Discovery Services Market for Diabetes, By Region, 2015–2022 (USD Million)
Table 26 Market for Other Therapeutic Areas, By Region, 2015–2022 (USD Million)
Table 27 Market, By Region, 2015–2022 (USD Million)
Table 28 North America: Drug Discovery Services Market, By Country, 2015–2022 (USD Million)
Table 29 North America: Market, By Process, 2015–2022 (USD Million)
Table 30 North America: Market, By Type, 2015–2022 (USD Million)
Table 31 North America: Market, By Drug Type, 2015–2022 (USD Million)
Table 32 North America: Market, By Therapeutic Area, 2015–2022 (USD Million)
Table 33 US: Drug Discovery Services Market, By Process, 2015–2022 (USD Million)
Table 34 US: Market, By Type, 2015–2022 (USD Million)
Table 35 US: Market, By Drug Type, 2015–2022 (USD Million)
Table 36 US: Market, By Therapeutic Area, 2015–2022 (USD Million)
Table 37 Canada: Drug Discovery Services Market, By Process, 2015–2022 (USD Million)
Table 38 Canada: Market, By Type, 2015–2022 (USD Million)
Table 39 Canada: Market, By Drug Type, 2015–2022 (USD Million)
Table 40 Canada: Market, By Therapeutic Area, 2015–2022 (USD Million)
Table 41 Europe: Pharmaceutical R&D Expenditure, By Country, 2012 & 2014
Table 42 Europe: Market, By Country/Region, 2015 –2022 (USD Million)
Table 43 Europe: Drug Discovery Services Market, By Process, 2015–2022 (USD Million)
Table 44 Europe: Market, By Type, 2015–2022 (USD Million)
Table 45 Europe: Market, By Drug Type, 2015–2022 (USD Million)
Table 46 Europe: Market, By Therapeutic Area, 2015–2022 (USD Million)
Table 47 Pharmaceutical R&D Investments in Germany (2010–2014)
Table 48 Germany: Drug Discovery Services Market, By Process, 2015–2022 (USD Million)
Table 49 Germany: Market, By Type, 2015–2022 (USD Million)
Table 50 Germany: Market, By Drug Type, 2015–2022 (USD Million)
Table 51 Germany: Market, By Therapeutic Area, 2015–2022 (USD Million)
Table 52 UK: Drug Discovery Services Market, By Process, 2015–2022 (USD Million)
Table 53 UK: Market, By Type, 2015–2022 (USD Million)
Table 54 UK: Market, By Drug Type, 2015–2022 (USD Million)
Table 55 UK: Market, By Therapeutic Area, 2015–2022 (USD Million)
Table 56 France: Drug Discovery Services Market, By Process, 2015–2022 (USD Million)
Table 57 France: Market, By Type, 2015–2022 (USD Million)
Table 58 France: Market, By Drug Type, 2015–2022 (USD Million)
Table 59 France: Market, By Therapeutic Area, 2015–2022 (USD Million)
Table 60 Pharmaceutical R&D Investments in Italy, 2009–2014
Table 61 Pharmaceutical R&D Expenditure in Belgium, 2010–2014
Table 62 Pharmaceutical Production and R&D Expenditure in Denmark, 2012–2014
Table 63 RoE: Drug Discovery Services Market, By Process, 2015–2022 (USD Million)
Table 64 RoE: Market, By Type, 2015–2022 (USD Million)
Table 65 RoE: Market, By Drug Type, 2015–2022 (USD Million)
Table 66 RoE: Market, By Therapeutic Area, 2015–2022 (USD Million)
Table 67 Total Number of Clinical Trials in APAC, By Therapeutic Area, 2016
Table 68 APAC: Drug Discovery Services Market, By Country/Region, 2015–2022 (USD Million)
Table 69 APAC: Market, By Process, 2015–2022 (USD Million)
Table 70 APAC: Market, By Type, 2015–2022 (USD Million)
Table 71 APAC: Market, By Drug Type, 2015–2022 (USD Million)
Table 72 APAC: Market, By Therapeutic Area, 2015–2022 (USD Million)
Table 73 China: Drug Discovery Services Market, By Process, 2015–2022 (USD Million)
Table 74 China: Market, By Type, 2015–2022 (USD Million)
Table 75 China: Market, By Drug Type, 2015–2022 (USD Million)
Table 76 China: Market, By Therapeutic Area, 2015–2022 (USD Million)
Table 77 Japan: Drug Discovery Services Market, By Process, 2015–2022 (USD Million)
Table 78 Japan: Market, By Type, 2015–2022 (USD Million)
Table 79 Japan: Market, By Drug Type, 2015–2022 (USD Million)
Table 80 Japan: Market, By Therapeutic Area, 2015–2022 (USD Million)
Table 81 India: Drug Discovery Services Market, By Process, 2015–2022 (USD Million)
Table 82 India: Market, By Type, 2015–2022 (USD Million)
Table 83 India: Market, By Drug Type, 2015–2022 (USD Million)
Table 84 India: Market, By Therapeutic Area, 2015–2022 (USD Million)
Table 85 RoAPAC: Drug Discovery Services Market, By Process, 2015–2022 (USD Million)
Table 86 RoAPAC: Market, By Type, 2015–2022 (USD Million)
Table 87 RoAPAC: Market, By Drug Type, 2015–2022 (USD Million)
Table 88 RoAPAC: Market, By Therapeutic Area, 2015–2022 (USD Million)
Table 89 RoW: Drug Discovery Services Market, By Process, 2015–2022 (USD Million)
Table 90 RoW: Market, By Type, 2015–2022 (USD Million)
Table 91 RoW: Market, By Drug Type, 2015–2022 (USD Million)
Table 92 RoW: Market, By Therapeutic Area, 2015–2022 (USD Million)

List of Figures (39 Figures)

Figure 1 Global Drug Discovery Services Market
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Data Triangulation Methodology
Figure 5 Drug Discovery Services Market, By Process, 2017 vs 2022 (USD Billion)
Figure 6 Global Market, By Type, 2017 vs 2022 (USD Billion)
Figure 7 Global Market, By Drug Type, 2017 vs 2022 (USD Billion)
Figure 8 Global Market, By Therapeutic Area, 2017 vs 2022 (USD Billion)
Figure 9 Global Market, By Region, 2017 vs 2022 (USD Billion)
Figure 10 Increasing Demand for Outsourcing of Analytical Testing and Clinical Trial Services to Drive Market Growth
Figure 11 Oncology Segment to Command the Largest Market Share of European Drug Discovery Services Market in 2017
Figure 12 Medicinal Chemistry to Register the Highest CAGR During the Forecast Period (2017-2022)
Figure 13 Asia Pacific to Register the Highest CAGR Between 2017 & 2022
Figure 14 Drug Discovery Services Market: Drivers, Restraints, and Opportunities
Figure 15 Number of Registered Studies (2000-2017)
Figure 16 Hit-To-Lead Identification to Hold Largest Market Share in 2017
Figure 17 Medicinal Chemistry Segment to Account for the Largest Share of the Drug Discovery Services Market
Figure 18 Small Molecules—The Largest Segment in the Global Market, By Drug Types
Figure 19 Oncology Segment to Hold the Largest Share in Global Market in 2017
Figure 20 Total Number of Clinical Trials for Oncology (2016)
Figure 21 Geographic Snapshot (2016): APAC Markets are Emerging as New Growth Hotspots
Figure 22 North America: Drug Discovery Services Market Snapshot
Figure 23 Pharmaceutical R&D Expenditure in the US (1990-2014)
Figure 24 Total Canadian Pharmaceutical Trade (2004–2016) (USD Billion)
Figure 25 Yearly Employment in Manufacturing Portion of Pharmaceutical Sector (2005–2016)
Figure 26 Pharmaceutical R&D Expenditure in Europe (2010–2014)
Figure 27 Europe: Market Snapshot
Figure 28 APAC: Market Snapshot
Figure 29 Global Market: Market Share (2016)
Figure 30 Thermo Fisher Scientific: Company Snapshot (2016)
Figure 31 Merck: Company Snapshot (2016)
Figure 32 GE Healthcare: Company Snapshot (2016)
Figure 33 Albany Molecular Research, Inc.: Company Snapshot (2016)
Figure 34 Charles River Laboratories International: Company Snapshot (2016)
Figure 35 Evotec: Company Snapshot (2016)
Figure 36 Jubilant Biosys: Company Snapshot (2016)
Figure 37 Labcorp: Company Snapshot (2016)
Figure 38 Genscript Biotech Corporation: Company Snapshot (2016)
Figure 39 Syngene: Company Snapshot (2016)



【レポートのキーワード】

創薬サービス、新薬開発、医薬品化学、生物学サービス、DMPK

★調査レポート[創薬サービスの世界市場予測(~2022年):医薬品化学、生物学サービス、DMPK] (コード:PH-5682)販売に関する免責事項を必ずご確認ください。
★調査レポート[創薬サービスの世界市場予測(~2022年):医薬品化学、生物学サービス、DMPK]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆